Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 900 studies
Open to sponsorsGeneral clinicalView Company states expertise across oncologycardiologynephrologyurology
SCALE 630 studies
Open to sponsorsGeneral clinicalView Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 400 studies
Open to sponsorsGeneral clinicalView Stated on the company's Who We Are page: "multiple therapeutic areas with a specific focus on Inflammation & PainInfectious DiseasesCentral Nervous systemsand Oncology".
SCALE 00 studies
Open to sponsorsGeneral clinicalView